These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23094763)

  • 1. Correlation of activated clotting times and standard laboratory coagulation tests in paediatric non-cardiac surgery.
    Haas T; Spielmann N; Mauch J; Schmugge M; Weiss M
    Scand J Clin Lab Invest; 2013 Feb; 73(1):29-33. PubMed ID: 23094763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
    Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of thromboelastometry (ROTEM®) with standard plasmatic coagulation testing in paediatric surgery.
    Haas T; Spielmann N; Mauch J; Madjdpour C; Speer O; Schmugge M; Weiss M
    Br J Anaesth; 2012 Jan; 108(1):36-41. PubMed ID: 22086509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.
    Kashuk JL; Moore EE; Le T; Lawrence J; Pezold M; Johnson JL; Cothren CC; Biffl WL; Barnett C; Sabel A
    J Surg Res; 2009 Sep; 156(1):133-8. PubMed ID: 19577246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of point-of-care testing (POCT): i-STAT(®) international normalized ratio (INR) vs reference laboratory INR in pediatric patients undergoing major surgery.
    Spielmann N; Mauch JY; Madjdpour C; Schmugge M; Albisetti M; Weiss M; Haas T
    Paediatr Anaesth; 2011 Oct; 21(10):1041-5. PubMed ID: 21545369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.
    Pitney MR; Kelly SA; Allan RM; Giles RW; McCredie M; Walsh WF
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):145-50. PubMed ID: 8808069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated clotting time (ACT).
    Horton S; Augustin S
    Methods Mol Biol; 2013; 992():155-67. PubMed ID: 23546712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated clotting time tests with heparinase in the management of pediatric patients on cardiopulmonary bypass.
    Kriesmer P; Payne NR; Tessmer J; Uden DL
    ASAIO J; 1993; 39(4):942-5. PubMed ID: 8123932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
    Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
    J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT Plus.
    Lewandrowski EL; Van Cott EM; Gregory K; Jang IK; Lewandrowski KB
    Am J Clin Pathol; 2011 May; 135(5):741-8. PubMed ID: 21502428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in heparin potency and effects on the activated clotting time in children undergoing cardiopulmonary bypass.
    Guzzetta NA; Amin SJ; Tosone AK; Miller BE
    Anesth Analg; 2012 Oct; 115(4):921-4. PubMed ID: 22822188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.